Immediate Impact
7 from Science/Nature 70 standout
Citing Papers
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
2022 Standout
Works of Paul Lloyd-Evans being referenced
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul Lloyd-Evans | 135 | 169 | 37 | 111 | 14 | 383 | |
| Elizabeth A. Stafford | 17 | 161 | 9 | 82 | 15 | 444 | |
| Jan Staelens | 44 | 134 | 4 | 37 | 11 | 344 | |
| Yu‐Hung Lin | 10 | 53 | 7 | 68 | 20 | 452 | |
| Dieter H�ussinger | 11 | 55 | 9 | 32 | 18 | 432 | |
| Jinduo Yuan | 36 | 101 | 7 | 18 | 10 | 363 | |
| Le Cheng | 68 | 63 | 21 | 13 | 22 | 354 | |
| Caizhi Liu | 12 | 85 | 2 | 66 | 15 | 338 | |
| Wendy L. Rose | 32 | 196 | 6 | 14 | 11 | 442 | |
| Anna Klaus | 66 | 156 | 7 | 6 | 11 | 445 | |
| H Nakajima | 20 | 189 | 36 | 15 | 17 | 382 |
All Works
Loading papers...